![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 21, 2020 8:31:03 AM
From :Crunchbase Daily
Telehealth Startup Nurx Rolling Out At-Home Test For COVID-19
Sophia Kunthara
March 20, 2020
Nurx, the telehealth startup known for delivering birth control and at-home sexually transmitted infection testing, is rolling out a home test for COVID-19.
The company’s long-time partner, Molecular Testing Labs, is developing the test, which will be available as soon as Friday afternoon.
“Drive-through testing is an option, but it doesn’t exist everywhere,” Dr. Chris Hall, Nurx’s senior medical adviser said in an interview with Crunchbase News. “We feel that all of the testing options are necessary to address this crisis, but we just feel like home-based testing is going to be a really important part of that.”
Nurx, which is based in San Francisco, has more than $93 million in funding and is backed by investors including Kleiner Perkinsand Union Square Ventures. It last raised $32 million for its Series C round in August 2019.
Nurx first published a blog post to answer a few questions about coronavirus, before the company realized it could play a bigger role in the solution. The startup has been working for about two weeks on making an at-home test available, Hall said, and has been meeting with Molecular Testing Labs multiple times every day, including weekends. The entire Nurx team has been working on rolling out the at-home COVID-19 test.
“We began to realize pretty quickly after creating that blog post that we were perfectly situated to pivot to this service,” he said.
While Nurx is perhaps best known for delivering birth control and the HIV-prevention medication PrEP, it has been in the at-home testing space for a while, providing testing kits for sexually transmitted infections, HIV, Hepatitis C and HPV.
Getting tested for coronavirus in the United States has been difficult, and Nurx is one of several startups working on making more COVID-19 tests available since the Food and Drug Administration gave certified labs the green light to develop and distribute them. Austin-based at-home testing startup EverlyWellalso announced plans to have an at-home COVID-19 test available next week. Los Angeles’ Scanwell Healthand San Francisco’s Carbon Health also announced home test kits.
A person wanting to get tested for the virus can use the Nurx app or website, indicate interest in the test and fill out a survey with questions about symptoms. A Nurx provider will then review the information and decide if the patient should be tested. If so, the company will send a test kit with expedited shipping and instructions on how to complete the test and how to send the kit back to Molecular Testing Labs’ facility in Vancouver, Washington.
To complete the test, patients will perform a throat swab. Molecular Testing Labs performs a polymerase chase reaction (PCR) test to determine if the patient has COVID-19.
A patient should receive results within 24 to 48 hours, Hall said, and Nurx will advise them what next steps they should take, such as isolation. Patients will receive automatic advice, but if they have unanswered questions they can communicate with a provider.
Nurx will have the test, which will cost under $200, available on a “limited basis” when it’s first introduced. The company’s planning to provide 10,000 home testing kits in the upcoming weeks and, according to a company spokeswoman, 100,000 tests in the near future.
“We are here to work with everyone just to increase the sheer number of tests that are out there,” Hall said. “No single provider and no single company or initiative is going to be able to solve this problem alone.”
Editor’s note: This article was updated post-publication to reflect that patients will now perform a throat swab rather than a nasal swab to complete the test.
Recent AYTU News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:09:09 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/18/2024 08:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 12:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:12:30 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/10/2024 08:07:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/10/2024 08:07:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/10/2024 08:06:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:12:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:25:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:37:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:05:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:05:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/12/2023 06:50:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:37:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 08:20:15 PM
- Wednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and more • IH Market News • 09/27/2023 11:28:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/18/2023 10:27:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 12:57:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:49:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:39:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:34:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM